Clinical Trials · NCT03519178
A Study of PF-06873600 in People With Cancer
- Phase
- Phase 1/Phase 2
- Recruitment status
- Terminated
- Sponsor
- Pfizer
- Enrollment
- 155
- Start date
- Mar 2018
- Locations
- 54 sites, 6 countries
- Primary endpoint
- Number of Participants With Dose Limiting Toxicities (DLTs) - Part 1